Activities of Theodoros SKYLAKAKIS related to 2012/2041(INI)
Plenary speeches (1)
Rising threats from antimicrobial resistance (short presentation)
Shadow reports (1)
REPORT on the Microbial Challenge – Rising threats from Antimicrobial Resistance PDF (224 KB) DOC (156 KB)
Amendments (18)
Amendment 4 #
Motion for a resolution
Citation 21 a (new)
Citation 21 a (new)
- having regard to the Preparatory Action voted by the European Parliament "Antimicrobial resistance (AMR): Research on the causes of high and improper antibiotic usage" in the framework of the Budget of the European Union for the financial year 2012, which aims at studying the issue of inappropriate use and sales of antimicrobial agents with or without prescription throughout the chain - from the doctor and the pharmacist to the patient, in terms of behaviour of all actors involved,
Amendment 10 #
Motion for a resolution
Recital D
Recital D
D. whereas the rise of antimicrobial resistance (AMR) is a complex issue driven by a variety of interconnected factors; whereas it has cross-border nature; whereas individual intervention measures will have minimal effect;
Amendment 29 #
Motion for a resolution
Recital H b (new)
Recital H b (new)
Hb. whereas the use of diagnostics have a vital role to play in combating AMR by encouraging more targeted approaches to treatment;
Amendment 31 #
Motion for a resolution
Paragraph 1
Paragraph 1
1. Considers that, while almost all Member States have developed national AMR strategies in accordance with the Council Recommendation on prudent use of antimicrobial agents in human medicine, progress with regard to meeting set objectives has been slow and uneven; calls for firm governmental commitment to full and timely implementation at national level;
Amendment 45 #
Motion for a resolution
Paragraph 3
Paragraph 3
3. Stresses that more efforts are needed to control the use of antimicrobials in the human and veterinary sectormedicine; strongly disapproves of the uncontrolled prophylactic use of antimicrobials in animal husbandry;
Amendment 61 #
Motion for a resolution
Paragraph 6 a (new)
Paragraph 6 a (new)
6a. Calls on the Commission and the Member States to encourage efforts to ensure that the practice of hospital epidemiologist becomes part of the everyday practice in hospitals;
Amendment 63 #
Motion for a resolution
Paragraph 6 a (new)
Paragraph 6 a (new)
6a. Underlines that the increased use of diagnostics is necessary to improve the accuracy of diagnoses, leading to a reduction in the use of antimicrobials;
Amendment 65 #
Motion for a resolution
Paragraph 6 b (new)
Paragraph 6 b (new)
6b. Calls on the Commission and the Member States to encourage efforts to study hospital outbreaks on a routine basis, as well as the possible role of the spread of drug-resistant clones in these outbreaks;
Amendment 69 #
Motion for a resolution
Paragraph 7
Paragraph 7
7. With a view to limiting the use and easy availability ofinappropriate use and uncontrolled access to antimicrobial agents, welcomes Member States' initiatives to review the legal status of all oral, inhaled and parenteral antibiotics (namelymicrobials (including antimalarial, antiviral and antifungal drugs) that remain available to patients without a prescription;
Amendment 76 #
Motion for a resolution
Paragraph 9
Paragraph 9
9. Calls on the Commission and Member States, in accordance with the competent EU Agencies, to devise and promote prudent use guidelines aimed at reducing non-essential and inappropriate exposure to antimicrobials in human and veterinary medicine, livestock farming, agriculture, aquaculture and horticulture;
Amendment 85 #
Motion for a resolution
Paragraph 9 c (new)
Paragraph 9 c (new)
9c. Calls on the Commission and Member States to increase the exchange of best practice on preventing and reducing healthcare associated infections (HAIs);
Amendment 91 #
Motion for a resolution
Paragraph 12
Paragraph 12
12. Calls on the Commission and the Member States to examine new regulatory approaches, including transferable intellectual property rights and patent term extensions, with a view to encouraging private-sector investment in antimicrobial development;
Amendment 92 #
Motion for a resolution
Paragraph 12 a (new)
Paragraph 12 a (new)
12a. Notes the importance of access to rapid, reliable and affordable diagnostic tools in the development of new treatment strategies;
Amendment 94 #
Motion for a resolution
Paragraph 12 a (new)
Paragraph 12 a (new)
12a. Calls on the Commission and the Member States to examine new regulatory approaches oriented towards subsidising research for the development of new antimicrobials which can have a fiscally beneficial result both for the public and the private sector;
Amendment 95 #
Motion for a resolution
Paragraph 12 b (new)
Paragraph 12 b (new)
12b. Calls on the Commission and Member States to strengthen incentives for public and private sector cooperation to reinvigorate antimicrobial research and development (R&D); believes that sharing knowledge and pooling resources through innovative public-private partnerships (PPPs) will be critical to ensuring the clinical efficacy and availability of existing antimicrobials;
Amendment 97 #
Motion for a resolution
Paragraph 12 d (new)
Paragraph 12 d (new)
12d. Calls on the Commission to ensure the development and availability of more on farm tools for early, rapid diagnosis and control of diseases, as well as a broad and effective diagnostic system at Member State level which can ensure the timely delivery of results in case bacteriological examinations are performed;
Amendment 108 #
Motion for a resolution
Paragraph 14 b (new)
Paragraph 14 b (new)
14b. Calls on the Commission and Member States to ensure that future measuring and reporting on the use of antimicrobials in both the human and veterinary sectors will be broadened out, showing not only the total amount of antimicrobials used but also types of antimicrobials, treatment times, etc.;
Amendment 110 #
Motion for a resolution
Paragraph 15
Paragraph 15
15. Notes that the encouragement of appropriate antimicrobial use depends on a change of attitude and practice among patients, farmers and, medical doctors, veterinarians and other practitioners in the spheres of human and veterinary and human medicine; considers that more effective and continuous educational and training measures should be taken at both national and European level;